LI He,RU Dan,ZHANG Xu,et al.Shanghai expert consensus on "whole period" diagnosis and reatment of ovarian cancer with integrated traditional Chinese and Western medicine[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(增刊1):88-96.
LI He,RU Dan,ZHANG Xu,et al.Shanghai expert consensus on "whole period" diagnosis and reatment of ovarian cancer with integrated traditional Chinese and Western medicine[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(增刊1):88-96. DOI: 10.16305/j.1007-1334.2024.17.
ovarian cancerShanghai school of Chinese medicine gynecologyintegrated traditional Chinese and Western medicinewhole period of treatmentexpert consensus
references
SIEGEL R L, MILLER K D, WAGLE N S, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48.
ZHANG M, HE Y, SUN X, et al. A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients[J]. J Ovarian Res, 2014, 7: 19.
WU X, FENG Q M, WANG Y, et al.The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy[J]. Cancer Immunol Immunother, 2010, 59(2): 279-291.